NLS Pharmaceutics AG (NLSPW) — Financial Flexibility Index
NLS Pharmaceutics AG (NLSPW) has a Financial Flexibility Index of -1.43x as of September 2025. Free cash flow of $-2.07 Million (operating CF $-2.07 Million minus capex $0.00) represents -1% of total liabilities ($1.46 Million). Check total reinvestment intensity of NLS Pharmaceutics AG to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
NLS Pharmaceutics AG Financial Flexibility Index (2017–2024)
Historical Financial Flexibility Index trend for NLS Pharmaceutics AG across 8 annual periods. For the full cash flow conversion analysis, see NLSPW cash flow metrics.
Annual Financial Flexibility Index for NLS Pharmaceutics AG (2017–2024)
Year-by-year free cash flow to debt coverage for NLS Pharmaceutics AG. Explore cash flow to debt ratio of NLS Pharmaceutics AG to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -5.16x | $-4.26 Million | $-4.27 Million | $826.76K | ▼ -468.8% |
| 2023 | -0.91x | $-9.68 Million | $-9.68 Million | $10.68 Million | ▲ +58.9% |
| 2022 | -2.21x | $-13.24 Million | $-13.88 Million | $6.00 Million | ▲ +22.6% |
| 2021 | -2.85x | $-14.90 Million | $-14.94 Million | $5.22 Million | ▼ -3887.3% |
| 2020 | -0.07x | $-729.38K | $-729.39K | $10.20 Million | ▼ -158.6% |
| 2019 | -0.03x | $-190.01K | $-190.01K | $6.87 Million | ▲ +90.9% |
| 2018 | -0.31x | $-2.73 Million | $-2.73 Million | $8.96 Million | ▲ +43.8% |
| 2017 | -0.54x | $-5.43 Million | $-5.43 Million | $10.01 Million | — |